Vicente Mirabet¹*, Pilar Solves² and Isabel Guillén³

¹Cell and Tissue Bank, Centro de Transfusión de Valencia, Spain ²Service of Haematology. Hospital Universitario y Politécnico La Fe, Spain ³Department of Pharmacy, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera CEU, Spain

*Corresponding Author: Vicente Mirabet, Cell and Tissue Bank, Centro de Transfusión de Valencia, Spain.

Received: August 10, 2023; Published: September 15, 2023

Abstract

Thousands of scientific articles related to the clinical use of platelet-rich plasma (PRP) are published worldwide every year; perhaps as many as PRP infiltrations are carried out daily in the health centers of our cities. A significant number of these studies and these infiltrations refer to the use of PRP to treat degenerative pathologies in elderly people, frequently, patients having a poor systemic condition, even with problems for blood drawing.

References

1. López-Otín C., et al. “The hallmarks of aging”. Cell6 (2013): 1194-1217.v
2. Campisi J. “"Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors”. Cell 4 (2005): 513-522.
3. Conboy IM., et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment”. Nature 7027 (2005): 760-764.
4. World Health Organization. “Blood safety and availability. www.who.int
5. Bottegoni C., et al. “Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study”. Therapeutic Advances in Musculoskeletal Disease2 (2016): 35-41.
6. Schallmoser K., et al. “Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells”. Transfusion8 (2007): 1436-1446.
7. Rebulla P., et al. "Multicentre standardisation of a clinical grade procedure for the preparation of allogeneic platelet concentrates from umbilical cord blood”. Blood Transfusion1 (2016): 73-79.
8. Samarkanova D., et al. “Cord blood-derived platelet concentrates as starting material for new therapeutic blood components prepared in a public cord blood bank: from product development to clinical application”. Blood Transfusion3 (2020): 208-216.

Citation

Citation: Vicente Mirabet., et al. “Autologous Platelet-Rich Plasma: Is it the Best Choice to Treat Degenerative Pathologies in the Elderly?". Acta Scientific Orthopaedics 6.10 (2023): 28-29.

Copyright

Copyright: © 2023 Vicente Mirabet., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.